Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
100%, Basel, fixed-term ETH Zurich is a world-leading university dedicated to advancing science and technology. The advertised position is based in the Computational Biology (CoBi) group led by Prof
-
100%, Zurich, fixed-term ETH Zurich is one of the world’s leading universities that specialize in science and technology. It is renowned for its excellent education, its cutting-edge fundamental
-
. Support high-quality trial delivery by managing country-specific risks and collaborating with affiliate teams and leadership to align local needs with global clinical development goals and regional
-
, rearing various insect species, and helping students and staff prepare their experiments. Profile You must be a current Bachelor or Master student at ETH or UZH, fluent in English, and comfortable working
-
essential for procedural success. Due to challenging imaging conditions, the quality of endoscopic videos can be significantly compromised by a range of artifacts. This project seeks to develop the next
-
80%-100%, Zurich, fixed-term About Tethys Robotics We are a Startup located in the center of Zürich that builds underwater drones. Our field of expertise is the development of highly integrated
-
university to be a place that promotes independent thinking and an environment that inspires excellence. Located in the heart of Europe, yet forging connections all over the world, we work together to develop
-
to establish an innovative platform for peptide drug discovery. Project background Peptides are privileged modalities for the development of new therapeutic avenues. To address unexploited targets and offer
-
80%-100%, Zurich, permanent ETH Zurich is one of the world’s leading universities specializing in science and technology. It is renowned for its excellent education, its cutting-edge research, and
-
, control engineering, and immunoengineering. This position is part of our newly funded ERC Advanced Grant, which aims to develop genetically engineered feedback control circuits in human T cells to tackle